OPSENS REPORTS Q3 2018 RESULTS – Quarterly Revenues Eclipse $6.4 M

Quebec City, Quebec, July 12, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2018. Highlights for the quarter Consolidated revenues reached $6,398,000 for the three-month period compared with $4,892,000 for the same period last year, an increase of $1,506,000 or 31%; Consolidated […]

Read More…

VISIT OPSENS AT THE CARDIOVASCULAR INNOVATIONS 2018 CONFERENCE

Learn more about the benefits of OptoWire® as a workhorse wire at the Cardiovascular Innovations (CVI) 2018 Conference by visiting us at the Opsens booth (#T4) or attend the complimentary educational lunch symposium with live case transmission sponsored by Opsens. RSVP Now!  Educational Lunch Symposium “Beyond FFR – Optimal Tools and Techniques for Coronary Physiology 2018” Sponsored by […]

Read More…

This website uses cookies to ensure you get the best experience on our website.